Public Citizen Accuses Pfizer of Building ‘Paxlovid Patent Wall,’ Pfizer Pushes Back Post author:PacConAdmin Post published:February 18, 2022 Post category:Drug Industry Daily The advocacy group Public Citizen is accusing Pfizer of building a “Paxlovid patent wall.” Source: Drug Industry Daily You Might Also Like PRAC Requests Supplementary Info From Antiretrovirals Related to Autoimmune Hepatitis April 3, 2018 Osiris Sues MiMedx Alleging Theft of Customers, Trade Secrets April 4, 2018 Fiscal 2017 Ends With Record High in ANDA Approvals October 5, 2017